Enveric Biosciences (ENVB) news

Recent news

Enveric Biosciences shares rise 10% after selecting lead drug candidate

Enveric Biosciences shares rise 10% after selecting lead drug candidate Enveric Biosciences, a biotechnology company specializing in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, recently announced that they…

AInvest Wire · Dec 28, 2023

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by